Presence of Anti-HBs Antibodies in Blood Donors 18-22 Years After Vaccination and Implications for the Selection of Candidates for Plasmapheresis for the Production of Hyperimmune Plasma
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Pan D, Liu H, Yao Z, Chen X, Li Y, Zhu J World J Gastrointest Oncol. 2024; 16(6):2504-2519.
PMID: 38994160 PMC: 11236260. DOI: 10.4251/wjgo.v16.i6.2504.
The management of a blood donor bitten by a snake.
Marano G, Franchini M, Catalano L, Vaglio S, Pupella S, Liumbruno G Ann Transl Med. 2018; 5(24):483.
PMID: 29299445 PMC: 5750295. DOI: 10.21037/atm.2017.12.02.
References
1.
FitzSimons D, Hendrickx G, Vorsters A, Van Damme P
. Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011. Vaccine. 2012; 31(4):584-90.
DOI: 10.1016/j.vaccine.2012.10.101.
View
2.
Zanetti A, Romano L, Giambi C, Pavan A, Carnelli V, Baitelli G
. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis. 2010; 10(11):755-61.
DOI: 10.1016/S1473-3099(10)70195-X.
View
3.
Gabbuti A, Romano L, Blanc P, Meacci F, Amendola A, Mele A
. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine. 2007; 25(16):3129-32.
DOI: 10.1016/j.vaccine.2007.01.045.
View
4.
. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet. 2000; 355(9203):561-5.
View
5.
Stroffolini T, Mele A, Tosti M, Gallo G, Balocchini E, Ragni P
. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol. 2000; 33(6):980-5.
DOI: 10.1016/s0168-8278(00)80132-4.
View